In particular, in lung squamous cell cancer, patients with wild-type TP53 had worse overall survival compared with patients with mutated p53 (multivariate analysis: HR = 0.636; 95% CI: 0.437–0.926; P = 0.018). This evidence concerns the gene TP53 and squamous cell lung carcinoma.